Composition and formulation comprising recombinant human iduronate-2-sulfatase and preparation method thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9896672
SERIAL NO

15184406

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A composition comprising recombinant iduronate-2-sulfatase (IDS) and a method for producing a purified recombinant IDS are provided. The glycosylation pattern and formylglycine content of the IDS composition are different from those of ELAPRASE® and have superior pharmaceutical efficacy and are safer than the conventional agent and thus can be effectively used for the therapy of Hunter syndrome.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GREEN CROSS CORPORATIONGIHEUNG-GU YONGIN-SI GYEONGGI-DO 446-770

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Choi, Yong Woon Yongin-si, KR 6 24
Chung, Yo Kyung Yongin-si, KR 8 25
Jin, Thong-Gyu Seoul, KR 9 24
Kim, Yong-Chul Yongin-si, KR 67 500
Paik, Sang Hoon Yongin-si, KR 14 89
Park, Yoo Chang Yongin-si, KR 5 24
Seo, Jinwook Yongin-si, KR 24 126
Son, Jong Mun Yongin-si, KR 5 24

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 20, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 20, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00